We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Gannett Co., Inc. (GCI) - free report >>
Elbit Systems Ltd. (ESLT) - free report >>
Krystal Biotech, Inc. (KRYS) - free report >>
Image: Bigstock
New Strong Sell Stocks for June 8th
Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:
ASLAN Pharmaceuticals Limited (ASLN - Free Report) operates as a clinical-stage biotechnology company. The Zacks Consensus Estimate for its current year earnings has been revised 14.3% downward over the last 30 days.
Cango Inc. (CANG - Free Report) provides an automotive transaction service platform. The Zacks Consensus Estimate for its current year earnings has been revised 58.7% downward over the last 30 days.
Elbit Systems Ltd. (ESLT - Free Report) develops and supplies a portfolio of airborne, land, and naval systems and products for defense, homeland security, and commercial aviation applications. The Zacks Consensus Estimate for its current year earnings has been revised 8.3% downward over the last 30 days.
Gannett Co., Inc. (GCI - Free Report) is a digitally focused media and marketing solutions company. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.
Krystal Biotech, Inc. (KRYS - Free Report) is a gene therapy company. The Zacks Consensus Estimate for its current year earnings has been revised 22.5% downward over the last 30 days.
View the entire Zacks Rank #5 List.